ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.716,42
-0,12%
S&P 500
5.246,68
0,48%
Dow Jones
39.558,11
0,32%
Euro vs US Dollar
1,08229
0,08%
Bitcoin
61.926,79
0,62%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. IceCure Medical Ltd (ICCM)

  7. IceCure Medical Ltd (ICCM) News

ICCM IceCure Medical Ltd

1,15
-0,01 (-0,86%)
15 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
IceCure Medical Ltd ICCM NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
-0,01 -0,86% 1,15 01:57:22
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
1,15 1,10 1,1669 1,12 1,16
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
07.5.202414:40EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07.5.202414:30PRNUSIndependent Study Results in Japan Demonstrate Zero (0%)..
15.4.202414:35PRNUSIceCure Medical Reports Final ICE3 Breast Cancer..
03.4.202414:30PRNUSIceCure Medical Reports Full Year 2023 Financial Results:..
03.4.202413:11IHMARKETNEWSU.S. Futures Dip in Pre-Market, May WTI and June Brent Crude..
02.4.202414:30PRNUSIceCure Submits FDA Regulatory Filing for New XSense™..
27.3.202413:30PRNUSIceCure Medical to Report 2023 Full Year Financial &..
19.3.202413:30PRNUSIceCure Medical Reports Positive Topline Results From ICE3..
12.3.202413:30PRNUSIceCure Receives Notice of Patent Allowance in Japan for a..
07.3.202414:30PRNUSIceCure Medical to Present at 34th Annual Oppenheimer..
04.3.202414:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04.3.202414:30PRNUSIceCure's ProSense® a Promising Alternative Treatment for..
27.2.202414:00PRNUSFourth BRIIT Conference in India Features IceCure's..
26.2.202414:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26.2.202414:00PRNUSStudy Using IceCure's ProSense® Treatment Results in 100%..
15.2.202414:00PRNUSIceCure's ProSense® to be Featured at Two Upcoming Medical..
30.1.202414:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30.1.202414:00PRNUSU.S. FDA Grants IceCure Medical's Appeal: Reopens De Novo..
29.1.202414:00PRNUSIceCure Medical's Breast Cryoablation Gains Prominence in..
16.1.202414:00PRNUSIceCure Medical's ProSense® Featured at Indian Society of..
12.1.202422:39EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
12.1.202422:18EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12.1.202422:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12.1.202422:05GLOBEIceCure Medical Regains Compliance with Nasdaq Minimum..
10.1.202414:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10.1.202414:00PRNUSIceCure Medical CEO Issues Letter to Shareholders & Reports..
03.1.202414:00PRNUSNew Study Reports IceCure's ProSense® Boosts Immune Response..
13.12.202314:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13.12.202314:00PRNUSStudy Using IceCure's ProSense® Finds: "Cryoablation Allows..
29.11.202314:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29.11.202314:00PRNUSIceCure's ProSense® Deepens Regulatory Approval in India
28.11.202314:00PRNUSIceCure System Successfully Treated Kidney Cancer Tumor with..
15.11.202314:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15.11.202314:00PRNUSIceCure Medical Reports Financial Results as of and for the..
15.11.202313:30PRNUSIceCure Medical Files Appeal with U.S. FDA Requesting a..
08.11.202314:00PRNUSIceCure Medical to Report Third Quarter 2023 Financial &..
06.11.202314:00PRNUSSubstantial Evidence-Based Data Currently Being Generated by..
03.11.202321:26EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03.11.202321:00PRNUSIceCure Medical Announces Receipt of Nasdaq Minimum Bid..
30.10.202313:00PRNUSIceCure's ICE3 Trial Results Demonstrating 96.91% Recurrence..
25.10.202314:00PRNUSIndependent Scientific Paper by Doctors Using IceCure's..
05.10.202314:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05.10.202314:00PRNUSWomen Deemed Inoperable for Breast Cancer Benefitted from..
02.10.202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02.10.202314:00PRNUSIndependent Study Validates IceCure's ProSense Cryoablation..
22.9.202314:00PRNUSRenowned Spanish Radiologist Lucía Graña-López to Present..
20.9.202313:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20.9.202313:00PRNUSIceCure Medical Receives FDA Response to De Novo..
08.9.202314:00PRNUSIceCure Medical to Join Hands-On Cryoablation Session with..
05.9.202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

Kürzlich von Ihnen besucht

NASDAQ
ICCM
IceCure Medical
COIN
JACBTC
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten